<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="102552">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01947660</url>
  </required_header>
  <id_info>
    <org_study_id>5492</org_study_id>
    <nct_id>NCT01947660</nct_id>
  </id_info>
  <brief_title>Continuous Regional Anesthesia for Septic Limb Orthopedic Surgery</brief_title>
  <acronym>ACOSM</acronym>
  <official_title>Continuous Regional Anesthesia for Septic Limb Orthopedic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <authority>France: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to assess the safety of using continuous regional anesthesia for
      post-operative analgesia during septic limb orthopedic surgery.

      The study hypothesis is that continuous regional anesthesia would not induce septic
      complication in the operated limb and could improve post-operative recovery.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">November 2015</completion_date>
  <primary_completion_date type="Anticipated">November 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Septic complication in the operated limb</measure>
    <time_frame>28 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Septic complication in the operated limb Pain score Nausea and vomiting</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">260</enrollment>
  <condition>Osteo Arthritis</condition>
  <condition>Cellulitis</condition>
  <arm_group>
    <arm_group_label>Continuous regional anesthesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Systemic analgesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Systemic analgesia + Continuous regional anesthesia</intervention_name>
    <description>Systemic analgesia + Continuous regional anesthesia, peri neural for the 2 to 4 first days post-operative</description>
    <arm_group_label>Continuous regional anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Systemic analgesia</intervention_name>
    <description>Systemic analgesia as usual</description>
    <arm_group_label>Systemic analgesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Osteo arthritis or cellulitis requiring surgical intervention

          -  anatomical possibility of regional anesthesia

          -  age &gt;18 ans

          -  written informed consent

        Exclusion Criteria:

          -  loco-regional anesthesia impossibility (puncture zone infection, local anesthesics
             allergie, amiodarone or mexil√©tine treatment, neurologic deficit for exemple)

          -  patient under tutelle or curatelle

          -  pregnant or beast feeding woman
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pierre DIEMUNSCH, PU PH</last_name>
    <phone>03 88 12 70 76</phone>
    <email>pierre.diemunsch@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eric NOLL, PH</last_name>
    <phone>03 88 55 23 37</phone>
    <email>eric.noll@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CCOM</name>
      <address>
        <city>Illkirch</city>
        <state>Alsace</state>
        <zip>67400</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eric NOLL, PH</last_name>
      <phone>03 88 55 23 37</phone>
    </contact>
    <investigator>
      <last_name>KEMPF, PU PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>NOLL, PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>GAUDIAS, PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>JENNY, PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>CLAVERT, PU PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>LAALOU, PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>BOERI, PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 17, 2013</lastchanged_date>
  <firstreceived_date>September 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Cellulitis</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
